Neuren Pharmaceuticals (NEU) Short Interest
Neuren Pharmaceuticals (ASX:NEU) had 4.22% of shares reported as short positions as of 24 Aug 2026, representing 5,354,132 shares. Neuren Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Neuren Pharmaceuticals
Neuren Pharmaceuticals is a biopharmaceutical company focused on developing therapies for neurological conditions. The company is positioned in the biotechnology sector, leveraging its expertise in neuroscience to address unmet medical needs. Neuren's unique value lies in its targeted approach to treating rare neurological disorders, with a strong pipeline of innovative products.
Short position
Neuren Pharmaceuticals (ASX:NEU) has 4.22% of its shares on issue reported as short positions as of 24 Aug 2026, or about 5,354,132 shares. Over the past 30 days that figure has fallen 0.85 percentage points, and over 90 days it has fallen 2.08 percentage points. Its highest recorded short interest was 6.47% in June 2026. NEU is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NEU intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Neuren Pharmaceuticals
Latest NEU news
All news- Neuren Pharmaceuticals (ASX:NEU): H1 Results, DAYBUE Growth and Dividend Explained - Kalkine
googlenews
- Neuren Pharmaceuticals (ASX:NEU) Shares Trade On Premium Despite Margin Compression - simplywall.st
googlenews
- Buy, hold, sell: Whitehaven, Endeavour, Neuren Pharmaceuticals shares
motleyfool
- Dividend/Distribution - NEU
asx
- Investor presentation, 26 August 2026
asx
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NEU
Start a research thread or post the first pulse update